A Phase IIb Randomized Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
2022 · American Journal of Respiratory and Critical Care Medicine · 92 citations
https://doi.org/10.1164/rccm.202112-2824oc
M
Majd Mouded
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
2.7K
Citations
19
h-index
22
i10-index
Majd Mouded is an academic researcher from Novartis (Switzerland). The author has contributed to research in topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Chronic Obstructive Pulmonary Disease (COPD) Research & Neonatal Respiratory Health Research. The author has an h-index of 19, co-authored 42 publications.
Papers by this author
worksNarcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy
2023 · Nature Communications · 56 citations
https://doi.org/10.1038/s41467-023-36120-z
Randomized Phase IIa Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
2022 · American Journal of Respiratory and Critical Care Medicine · 41 citations
https://doi.org/10.1164/rccm.202205-0868le
Novel loci and biomedical consequences of iron homoeostasis variation
2024 · Communications Biology · 9 citations
https://doi.org/10.1038/s42003-024-07115-3
A FinnGen pilot clinical recall study for Alzheimer’s disease
2023 · Scientific Reports · 8 citations
https://doi.org/10.1038/s41598-023-39835-7
Genome-wide meta-analysis conducted in three large biobanks expands the genetic landscape of lumbar disc herniations
2024 · Nature Communications · 7 citations
https://doi.org/10.1038/s41467-024-53467-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat